|
MechanismEGFR antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.India |
First Approval Date11 Sep 2006 |
100 Clinical Results associated with Laboratorios PiSA SA de CV
0 Patents (Medical) associated with Laboratorios PiSA SA de CV
100 Deals associated with Laboratorios PiSA SA de CV
100 Translational Medicine associated with Laboratorios PiSA SA de CV